Stock Events

Jazz Pharmaceuticals (JAZZ) Q3 2023 Earnings

8NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.07
1.59
3.25
4.91

Details

Expected EPS
4.91
Actual EPS
4.84
Surprise EPS
-0.07
Surprise Percent
+1.43%

Description

Jazz Pharmaceuticals (JAZZ) has reported earnings of 4.84 per share for Q3 2023.

0 Comments

Share your thoughts